Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
As a new crypto investor, it's crucial to know what to watch out for to avoid costly mistakes. Equip yourself with knowledge to navigate the market safely.
27,825 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
SpaceX is hinting at a bold new business path beyond rockets and Starlink. This article breaks down what spacex's sta...
As Uniti maps out its path for 2026, investors want clarity on revenue, cash flow, and growth prospects. This guide b...
When Nvidia shares stumble, savvy investors look for high-potential AI names that can keep delivering. Here are two s...
Walmart recently released its latest quarterly results, but the stock moved on macro concerns as much as fundamentals...
When a CEO sells a large block of stock, investors take notice. This article breaks down what nLIGHT's sold nearly 25...
The dramatic shift policy just signaled by the Fed has set the stage for a new era in healthcare investing. Bristol M...
Nvidia publicly praising Marvell Technology sparked a sharp price move and fresh debate about AI-driven growth. This ...
C3.ai has faced a dramatic 2026 drop, leaving investors wondering if the stock is a hidden bargain or a value trap. T...
A rare earth stock once-in-a-decade moment might be unfolding in the US with USA Rare Earth. This article breaks down...
As AI workloads surge, memory players like MICRON TECHNOLOGY (MU) stand at a crossroads. This guide breaks down how g...
Opendoor Technologies stock down discordant headlines have traders wondering if a rebound is possible. This article b...